AU9069291A - Use of angiotensin ii receptor antagonists for the preparation of a medicament for improving cognitive function - Google Patents
Use of angiotensin ii receptor antagonists for the preparation of a medicament for improving cognitive functionInfo
- Publication number
- AU9069291A AU9069291A AU90692/91A AU9069291A AU9069291A AU 9069291 A AU9069291 A AU 9069291A AU 90692/91 A AU90692/91 A AU 90692/91A AU 9069291 A AU9069291 A AU 9069291A AU 9069291 A AU9069291 A AU 9069291A
- Authority
- AU
- Australia
- Prior art keywords
- angiotensin
- medicament
- preparation
- receptor antagonists
- cognitive function
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909027197A GB9027197D0 (en) | 1990-12-14 | 1990-12-14 | Medicaments |
GB9027197 | 1990-12-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU9069291A true AU9069291A (en) | 1992-07-08 |
Family
ID=10687033
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU90692/91A Abandoned AU9069291A (en) | 1990-12-14 | 1991-12-12 | Use of angiotensin ii receptor antagonists for the preparation of a medicament for improving cognitive function |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0561896A1 (en) |
JP (1) | JPH06503338A (en) |
AU (1) | AU9069291A (en) |
GB (1) | GB9027197D0 (en) |
WO (1) | WO1992010186A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5185351A (en) * | 1989-06-14 | 1993-02-09 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists |
EP0577025A3 (en) * | 1992-07-01 | 1998-02-04 | Hoechst Aktiengesellschaft | Angiotensin-ii-receptorantagonist for the treatment and prophylaxis of coronary heart diseases |
US20100120694A1 (en) | 2008-06-04 | 2010-05-13 | Synergy Pharmaceuticals, Inc. | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
EP2527360B1 (en) | 2007-06-04 | 2015-10-28 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
US8034782B2 (en) | 2008-07-16 | 2011-10-11 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
EA201592263A1 (en) | 2013-06-05 | 2016-05-31 | Синерджи Фармасьютикалз, Инк. | ULTRASCULAR AGONISTS OF GUANYLACYCLASE C, METHOD OF THEIR RECEIVING AND USING |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5015651A (en) * | 1988-01-07 | 1991-05-14 | E. I. Du Pont De Nemours And Company | Treatment of hypertension with 1,2,4-angiotensin II antagonists |
CA2018443A1 (en) * | 1989-06-14 | 1990-12-14 | Joseph A. Finkelstein | Imidazolyl-alkenoic acids |
CA2018438C (en) * | 1989-06-14 | 2000-08-08 | Joseph Alan Finkelstein | Imidazolyl-alkenoic acids |
US5140037A (en) * | 1990-03-20 | 1992-08-18 | E. I. Du Pont De Nemours And Company | Treatment of central nervous system disorders with imidazole angiotensin-ii receptor antagonists |
-
1990
- 1990-12-14 GB GB909027197A patent/GB9027197D0/en active Pending
-
1991
- 1991-12-12 WO PCT/GB1991/002224 patent/WO1992010186A1/en not_active Application Discontinuation
- 1991-12-12 EP EP92900687A patent/EP0561896A1/en not_active Withdrawn
- 1991-12-12 JP JP4501731A patent/JPH06503338A/en active Pending
- 1991-12-12 AU AU90692/91A patent/AU9069291A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0561896A1 (en) | 1993-09-29 |
WO1992010186A1 (en) | 1992-06-25 |
JPH06503338A (en) | 1994-04-14 |
GB9027197D0 (en) | 1991-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU8374491A (en) | Angiotensin II receptor antagonists | |
AU3665793A (en) | Fibrinogen receptor antagonists | |
AU4396193A (en) | 3-benzylamino-2-phenyl-piperidine derivatives as substance p receptor antagonists | |
AU8477891A (en) | Fibrinogen receptor antagonists | |
AU6062590A (en) | Pharmaceutically active compounds | |
AU5194496A (en) | 5-HT4 receptor antagonists | |
AU3920693A (en) | Four novel receptors of the TGF-beta receptor family | |
AU5093293A (en) | Alicyclic compounds as tachykinin receptor antagonists | |
ZA98691B (en) | Use of central cannabinoid receptor antagonists for the preparation of drugs | |
GB9020051D0 (en) | Muscarinic receptor antagonists | |
AU3276293A (en) | Angiotensin II receptor antagonists | |
EP0711559A3 (en) | Use of phosphatidylserines for the manufacture of a medicament for improving cerebration | |
AU9064991A (en) | Use of angiotensin ii receptor antagonists in the treatment of diabetic retinopathy | |
EP0488959A3 (en) | New uses of competitive nmda receptor antagonists | |
AU3949889A (en) | The reductive amination of hydroxy-containing compounds | |
AU1784992A (en) | Subunit of the human interleukin-3 receptor | |
AU8720791A (en) | Disposable dispenser for powder | |
AU9069291A (en) | Use of angiotensin ii receptor antagonists for the preparation of a medicament for improving cognitive function | |
AU4377793A (en) | Alternative receptor therapy | |
AU3981989A (en) | Improved eyedrop dispenser | |
AU1919992A (en) | Angiotensin ii receptor antagonist thiazole devivatives | |
AU5322994A (en) | Fibrinogen receptor antagonists | |
AU1583492A (en) | Use of sigma receptor antagonists for treatment of amphetamine abuse | |
AU8225391A (en) | The use of inositolmonophosphate for the preparing of a medicament effective as a neuropeptide gamma-antagonist | |
AU9064191A (en) | Use of angiotensin ii receptor antagonists in the treatment of atheroma |